CORPORATE ACCESS

Live Conference Call and Webcast Scheduled for November 9, 2017, at 4:30 p.m. ETENGLEWOOD, Colo., Nov. 2, 2017 -- Aytu BioScience, Inc. (NASDAQ: AYTU), a specialty life sciences company focused on global commercialization of novel products in the field of urology,...

ENGLEWOOD, Colo., Nov. 1, 2017 -- Aytu BioScience, Inc. (NASDAQ: AYTU), a specialty life sciences company focused on global commercialization of novel products in the field of urology, today announced that it presented six posters demonstrating the clinical potential...

ENGLEWOOD, Colo., Oct. 26, 2017 -- Aytu BioScience, Inc. (NASDAQ: AYTU), a specialty life sciences company focused on global commercialization of novel products in the field of urology, today provided an update on the ongoing launch of Natesto in the U.S. Through...

ENGLEWOOD, Colo., Oct. 19, 2017 -- Aytu BioScience, Inc. (OTCQX: AYTU), a specialty life sciences company focused on global commercialization of novel products in the field of urology, today announced that the Company will ring the NASDAQ closing bell on Friday,...

ENGLEWOOD, Colo., Oct. 18, 2017 -- Aytu BioScience, Inc. (OTCQX: AYTU), a specialty life sciences company focused on global commercialization of novel products in the field of urology, today announced that its shares of common stock were approved for listing on The...

Company invites individual and institutional investors as well as advisors to log-on to VirtualInvestorConferences.com to view presentation ENGLEWOOD, Colo., Oct. 9, 2017 -- Aytu BioScience (OTCQX: AYTU), a specialty life sciences company focused on global...

ENGLEWOOD, Colo., Oct. 3, 2017 -- Aytu BioScience, Inc. (OTCQX: AYTU), a specialty life sciences company focused on global commercialization of novel products in the field of urology, today announced that the company has entered into a distribution agreement with...

Company invites individual and institutional investors as well as advisors to attend interactive real-time virtual VirtualInvestorConferences.com ENGLEWOOD, Colo., Sept. 28, 2017 -- Aytu BioScience (OTCQX: AYTU), a specialty life sciences company focused on global...

Temporary Ticker Symbol 'AYTUD' is No Longer Active as of September 28, 2017ENGLEWOOD, Colo., Sept. 28, 2017 -- Aytu BioScience, Inc. (OTCQX: AYTU), a specialty life sciences company focused on global commercialization of novel products in the field of urology, today...

ENGLEWOOD, Colo., Aug. 29, 2017 -- Aytu BioScience, Inc. (OTCQX: AYTU), a specialty life sciences company focused on global commercialization of novel products in the field of urology, today announced that a previously announced 1-for-20 reverse split of its...

ENGLEWOOD, Colo., Aug. 25, 2017 -- Aytu BioScience, Inc. (OTCQX: AYTU), a specialty life sciences company focused on global commercialization of novel products in the field of urology, today announced that a previously approved 1-for-20 reverse split of its...

Live Conference Call and Webcast Scheduled for August 31, 2017, at 10:30 a.m. ETENGLEWOOD, Colo., Aug. 24, 2017 -- Aytu BioScience, Inc. (OTCQX: AYTU), a specialty life sciences company focused on global commercialization of novel products in the field of urology,...

ENGLEWOOD, Colo., Aug. 15, 2017 -- Aytu BioScience, Inc. (OTCQX: AYTU) a specialty pharmaceutical company focused on global commercialization of novel products in the field of urology, today announced the closing, on August 15, 2017, of its previously disclosed...

ENGLEWOOD, Colo., Aug. 11, 2017 -- Aytu BioScience, Inc. (OTCQX: AYTU) a specialty pharmaceutical company focused on global commercialization of novel products in the field of urology, today announced that it has received subscriptions for a private placement in the...

ENGLEWOOD, Colo., July 13, 2017 -- Aytu BioScience, Inc. (OTCQX: AYTU), a specialty pharmaceutical company focused on global commercialization of novel products in the field of urology, today announced the signing of an exclusive distribution agreement for...

ENGLEWOOD, Colo., July 5, 2017 -- Aytu BioScience, Inc. (OTCQX: AYTU), a specialty pharmaceutical company focused on global commercialization of novel products in the field of urology, today announced seven presentations at the European Society of Human Reproduction...

ENGLEWOOD, Colo., June 19, 2017 -- Aytu BioScience, Inc. (OTCQX: AYTU), a specialty pharmaceutical company focused on global commercialization of novel products in the field of urology, today announced the hiring of Gregory A. Gould as the company's full-time Chief...

ENGLEWOOD, Colo., May 17, 2017 -- Aytu BioScience, Inc. (OTCQX: AYTU), a specialty pharmaceutical company focused on global commercialization of novel products in the field of urology, today announced that it presented one poster presentation illustrating safety...

ENGLEWOOD, Colo., May 15, 2017 -- Aytu BioScience, Inc. (OTCQX: AYTU), a specialty pharmaceutical company focused on global commercialization of novel products in the field of urology, today announced that it presented two posters demonstrating new clinical findings...

Live Conference Call and Webcast TODAY at 4:30 p.m. ETENGLEWOOD, Colo., May 11, 2017 -- Aytu BioScience, Inc. (OTCQX: AYTU), a specialty life sciences company focused on global commercialization of novel products in the field of urology, today provided an overview of...

ENGLEWOOD, Colo., May 9, 2017 -- Aytu BioScience, Inc. (OTCQX: AYTU), a specialty life sciences company focused on global commercialization of novel products in the field of urology, today announced the acquisition of Nuelle, Inc. ('Nuelle"), a women's sexual health...

Live Conference Call and Webcast Scheduled for May 11, 2017, at 4:30 p.m. ETENGLEWOOD, Colo., May 3, 2017 -- Aytu BioScience, Inc. (OTCQX: AYTU), a specialty pharmaceutical company focused on global commercialization of novel products in the field of urology, today...

ENGLEWOOD, Colo., April 4, 2017 -- Aytu BioScience, Inc. (OTCQX: AYTU), a specialty pharmaceutical company focused on global commercialization of novel products in the field of urology, today announced that it presented two posters demonstrating the safety advantages...

Sale Price of $1.75 Million in Cash Further Supports Ongoing Commercialization of Natesto®ENGLEWOOD, Colo., April 3, 2017 -- Aytu BioScience, Inc. (OTCQX: AYTU), a specialty pharmaceutical company focused on global commercialization of novel products in the field...

ENGLEWOOD, Colo., March 14, 2017 -- Aytu BioScience, Inc. (OTCQX: AYTU), a specialty pharmaceutical company focused on global commercialization of novel products in the field of urology, today announced the publication of a peer-reviewed journal article demonstrating...

ENGLEWOOD, Colo., March 1, 2017 -- Aytu BioScience, Inc. (OTCQX: AYTU), a specialty pharmaceutical company focused on global commercialization of novel products in the field of urology, today announced the successful completion of its tender offer to amend and...

Increasing Number of U.S. Territories by 20%ENGLEWOOD, Colo., Feb. 22, 2017 -- Aytu BioScience, Inc. (OTCQX: AYTU), a specialty pharmaceutical company focused on global commercialization of novel products in the field of urology, today announced the expansion of its...

Product Revenues Increased 77% from Same Quarter in Prior Year; Cash Burn Reduced by 47% from Previous QuarterForecasting Cash Flow Breakeven in ~18 MonthsLive Conference Call and Webcast TODAY at 4:30 p.m. ETENGLEWOOD, Colo., Feb. 9, 2017 -- Aytu BioScience, Inc....

ENGLEWOOD, Colo., Feb. 1, 2017 -- Aytu BioScience, Inc. (OTCQX: AYTU), a specialty pharmaceutical company focused on global commercialization of novel products in the field of urology, today announced that two posters demonstrating clinical data for Natesto®...

Live Conference Call and Webcast Scheduled for February 9, 2017, at 4:30 p.m. ETENGLEWOOD, Colo., Jan. 31, 2017 -- Aytu BioScience, Inc. (OTCQX: AYTU), a specialty pharmaceutical company focused on global commercialization of novel products in the field of urology,...

Presentation on Tuesday, January 31st at 1:30 pm ETENGLEWOOD, Colo., Jan. 24, 2017 -- Aytu BioScience, Inc. (OTCQX: AYTU), a specialty pharmaceutical company focused on global commercialization of novel products in the field of urology, today announced that Josh...

ENGLEWOOD, Colo., Jan. 18, 2017 -- Aytu BioScience, Inc. (OTCQX: AYTU), a specialty pharmaceutical company focused on global commercialization of novel products in the field of urology, today announced that two posters demonstrating clinical data for Natesto®...

Presentation on Monday, January 9th at 9:30 AM Pacific TimeENGLEWOOD, Colo., Jan. 4, 2017 -- Aytu BioScience, Inc. (OTCQX: AYTU), a specialty pharmaceutical company focused on global commercialization of novel products in the field of urology, today announced that...

Signs Distribution Agreements with Established Medical Distributors in Japan, Korea, Hong Kong, Macau, and IndiaENGLEWOOD, Colo., Dec. 15, 2016 -- Aytu BioScience, Inc. (OTCQX: AYTU), a specialty pharmaceutical company focused on global commercialization of novel...

Company invites individual and institutional investors as well as advisors to log-on to VirtualInvestorConferences.com to view presentation ENGLEWOOD, Colo., Dec, 5, 2016 -- Aytu Bioscience Inc. (OTCQX: AYTU), a specialty pharmaceutical company focused on global...

Presentation on Thursday, December 8th at 9:30 AM PTENGLEWOOD, Colo., Dec. 1, 2016 -- Aytu BioScience, Inc. (OTCQX: AYTU), a specialty pharmaceutical company focused on global commercialization of novel products in the field of urology, today announced that Josh...

Natesto Improves All Five Domains of Erectile FunctionENGLEWOOD, Colo., Nov. 30, 2016 -- Aytu BioScience, Inc. (OTCQX: AYTU), a specialty pharmaceutical company focused on global commercialization of novel products in the field of urology, today announced the summary...

Company invites individual and institutional investors to attend interactive real-time virtual VirtualInvestorConferences.comENGLEWOOD, Colo., Nov. 28, 2016 -- Aytu BioScience, Inc. (OTCQX: AYTU), a specialty pharmaceutical company focused on global commercialization...

Data Establishes a Clear Protocol for Reproducible Sampling and a Clinical Cut-Off Value for Distinguishing Infertile MenENGLEWOOD, Colo., Nov. 17, 2016 -- Aytu BioScience, Inc. (OTCQX: AYTU), a specialty pharmaceutical company focused on global commercialization of...

Live Conference Call and Webcast TODAY at 4:30 p.m. ETENGLEWOOD, Colo., Nov. 7, 2016 -- Aytu BioScience, Inc. (OTCQX: AYTU), a specialty pharmaceutical company focused on global commercialization of novel products in the field of urology, provided today an overview of...

Live Conference Call and Webcast Scheduled for November 7, 2016, at 4:30 p.m. ETENGLEWOOD, Colo., Nov. 3, 2016 -- Aytu BioScience Inc. (OTCQX: AYTU), a specialty pharmaceutical company focused on global commercialization of novel products in the field of urology,...

ENGLEWOOD, Colo., Nov. 2, 2016 -- Aytu BioScience, Inc. (OTCQX: AYTU), a specialty pharmaceutical company focused on global commercialization of novel products in the field of urology, today announced the closing of its previously announced underwritten public...

Presents Clinical Findings at 72nd Annual Meeting of the American Society of Reproductive MedicineENGLEWOOD, Colo., Nov. 1, 2016 -- Aytu BioScience, Inc. (OTCQX: AYTU), a specialty pharmaceutical company focused on global commercialization of novel products in the...

ENGLEWOOD, Colo., Sept. 14, 2016 -- Aytu BioScience Inc. (OTCQX: AYTU), a specialty pharmaceutical company focused on global commercialization of novel products in the field of urology, today announced that it will present at two upcoming investor conferences in...

Company invites individual and institutional investors as well as advisors to log-on to VirtualInvestorConferences.com to view presentation ENGLEWOOD, Colo., Sept. 13, 2016 -- Aytu BioScience Inc. (OTCQX: AYTU), a specialty pharmaceutical company focused on global...

Company invites individual and institutional investors to attend interactive real-time virtual VirtualInvestorConferences.com ENGLEWOOD, Colo., Sept. 6, 2016 --Aytu BioScience Inc. (OTCQX: AYTU), a specialty pharmaceutical company focused on global commercialization...

ENGLEWOOD, Colo., Sept. 6, 2016 -- Aytu BioScience Inc. (OTCQX: AYTU), a specialty pharmaceutical company focused on global commercialization of novel products in the field of urology, today announced that Chief Operating Officer Jarrett Disbrow will present at the...

Live Conference Call and Webcast Today at 4:30 p.m. ETENGLEWOOD, Colo., Sept. 1, 2016 -- Aytu BioScience, Inc. (OTCQX: AYTU), a specialty pharmaceutical company focused on global commercialization of novel products in the field of urology, provided today a review of...

Live Conference Call and Webcast Scheduled for September 1, 2016, at 4:30 p.m. ETENGLEWOOD, Colo., Aug. 25, 2016 -- Aytu BioScience Inc. (OTCQX: AYTU), a specialty pharmaceutical company focused on global commercialization of novel products in the field of urology,...

ENGLEWOOD, Colo., Aug. 18, 2016 -- Aytu BioScience Inc. (OTCQX: AYTU), a specialty pharmaceutical company focused on global commercialization of novel products in the field of urology, today announced that it will present at the Rodman & Renshaw 18th Annual Global...